Akt/mTOR pathway was highly activated in CRPC [26–28] and p-Akt was reported to target and stimulate the expression of tumorigenic factors like c-MYC [16], SOX2 [29, 30], OCT4 [31] and eventually robust tumor growth. The gene discussed is AKT1; the disease is neoplasm.